Elite Pharmaceuticals Inc (ELTP)

[ARbigguy1]

Let’s speculate! FDA and DEA are calling on manufacturers to relinquish their remaining 2023 quota allotment since they were short producing about a BILLION doses of Adderall. Let say they do relinquish all or even going low to maybe 10% of their allotment.
We know and it has been stated in ELTP’s report transcripts (go read it for yourself) that ELTP has been able to get API where other manufacturers have struggled. ELTP has met and manufactured their allotment of Adderall which is evident in their continued increasing revenue.
So let say ELTP does pick up some of the relinquished Adderall to help relieve the huge short of the drug.
Full billion relinquished –
1 billion X $0.29 = $290,000,000
10% relinquished – $29,000,000
If ELTP can pick up any of the possible relinquished allotment of Adderall, IT WILL INCREASE ELTP REVENUE!!!
FDA and DEA joint letter regarding Adderall shortage –
https://www.fda.gov/media/170736/download?attachment
Adderall without insurance costs nearly $11 per tablet
https://www.singlecare.com/blog/adderall-without-insurance/
A manufacturer sales generic Adderall for approximately $0.29 based on the cost info below. (Conservative using 20X - $5.81/20=$0.29)
Publicly available data shows Veterans Affairs pays $2.61 a pill for the extended-release version of Adderall from Takeda. The agency pays $5.81 per pill for the immediate-release formula from Teva.
The branded cost is a magnitude higher - 15 to 20 times higher.
https://www.investors.com/news/technology/teva-stock-what-we-know-and-do-not-about-the-adderall-shortage/